TY - JOUR
T1 - Scaffold biomaterials and nano-based therapeutic strategies for skeletal muscle regeneration
AU - Tacchi, Franco
AU - Orozco-Aguilar, Josué
AU - Gutiérrez, Danae
AU - Simon, Felipe
AU - Salazar, Javier
AU - Vilos, Cristian
AU - Cabello-Verrugio, Claudio
N1 - Publisher Copyright:
© 2021 Future Medicine Ltd.
PY - 2021/12
Y1 - 2021/12
N2 - Skeletal muscle is integral to the functioning of the human body. Several pathological conditions, such as trauma (primary lesion) or genetic diseases such as Duchenne muscular dystrophy (DMD), can affect and impair its functions or exceed its regeneration capacity. Tissue engineering (TE) based on natural, synthetic and hybrid biomaterials provides a robust platform for developing scaffolds that promote skeletal muscle regeneration, strength recovery, vascularization and innervation. Recent 3D-cell printing technology and the use of nanocarriers for the release of drugs, peptides and antisense oligonucleotides support unique therapeutic alternatives. Here, the authors present recent advances in scaffold biomaterials and nano-based therapeutic strategies for skeletal muscle regeneration and perspectives for future endeavors.
AB - Skeletal muscle is integral to the functioning of the human body. Several pathological conditions, such as trauma (primary lesion) or genetic diseases such as Duchenne muscular dystrophy (DMD), can affect and impair its functions or exceed its regeneration capacity. Tissue engineering (TE) based on natural, synthetic and hybrid biomaterials provides a robust platform for developing scaffolds that promote skeletal muscle regeneration, strength recovery, vascularization and innervation. Recent 3D-cell printing technology and the use of nanocarriers for the release of drugs, peptides and antisense oligonucleotides support unique therapeutic alternatives. Here, the authors present recent advances in scaffold biomaterials and nano-based therapeutic strategies for skeletal muscle regeneration and perspectives for future endeavors.
KW - muscle wasting
KW - nanocarriers
KW - tissue engineering
KW - volumetric muscle loss
UR - http://www.scopus.com/inward/record.url?scp=85120701724&partnerID=8YFLogxK
U2 - 10.2217/nnm-2021-0224
DO - 10.2217/nnm-2021-0224
M3 - Review article
AN - SCOPUS:85120701724
SN - 1743-5889
VL - 16
SP - 2521
EP - 2538
JO - Nanomedicine
JF - Nanomedicine
IS - 28
ER -